|
31/01/2005
Targanta appoints Chief Scientific Officer
27/01/2005
Phagetech announces name change to Targanta Therapeutics
10/09/2004
Phagetech identifies a new chemical series against resistant strains of S. aureus.
12/01/2004
Bacteriophage genomics approach to antimicrobial drug discovery published by PhageTech in Nature Biotechnology
15/09/2003
Phages Point the Way to Novel Targets for Antimicrobial Drug Discovery;
PhageTech Drug Discovery Platform Presented at ICAAC
23/06/2003
Phagetech appoints former Pfizer R&D; executive, Pierre Etienne, M.D., President and Chief Executive Officer
19/6/2002
PhageTech Receives US Patent Covering Novel Target and Method of Discovering New Antibiotics to Fight Staph aureus
|